These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6358176)

  • 21. Outbreak of extended-spectrum beta-lactamase producing Serratia marcescens in an intensive care unit.
    Pagani L; Luzzaro F; Ronza P; Rossi A; Micheletti P; Porta F; Romero E
    FEMS Immunol Med Microbiol; 1994 Nov; 10(1):39-46. PubMed ID: 7874077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversion to bacillary forms of Serratia marcescens spheroplasts induced by carbenicillin. Scanning electron microscopic study.
    Furutani A; Tada Y; Yamaguchi J
    Microbiol Immunol; 1985; 29(10):901-7. PubMed ID: 3908886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.
    Su PA; Wu LT; Cheng KC; Ko WC; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2010 Feb; 43(1):26-34. PubMed ID: 20434120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a nosocomially significant, multiple drug-resistant strain of Serratia marcescens.
    Traub WH; Kleber I; Pühler A; Burkardt HJ
    Chemotherapy; 1976; 22(5):297-312. PubMed ID: 181215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
    Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
    Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergy of vancomycin with penicillins and cephalosporins against pseudomonas, klebsiella, and serratia.
    Donabedian H; Andriole VT
    Yale J Biol Med; 1977; 50(2):165-76. PubMed ID: 408984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics.
    Ramadan MA; Tawfik AF; Shibl AM
    Chemotherapy; 1995; 41(3):193-9. PubMed ID: 7656665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. beta-Lactamases and resistance to penicillins and cephalosporins in Serratia marcescens.
    Farrar WE; O'dell NM
    J Infect Dis; 1976 Sep; 134(3):245-51. PubMed ID: 789784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro sensitivity of hospital strains of Serratia marcescens to chemotherapeutic agents.
    Verbist L; Spaepen J; Vandepitte J
    Chemotherapy; 1976; 22(1):43-54. PubMed ID: 767065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro evaluation of alaphosphin (Ro 03-7008) against Serratia marcescens.
    Traub WH
    Chemotherapy; 1980; 26(2):103-10. PubMed ID: 6988181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Netilmicin: in-vitro activity compared with that of other aminoglycosides against Serratia marcescens.
    Langstaff D; Schueler S; Righter J
    J Antimicrob Chemother; 1983 Feb; 11(2):187-9. PubMed ID: 6339461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First detection of OKP-A β-lactamase in two Serratia marcescens isolates in China.
    Zou L; Pan X; Wu Q; Luo Y; Liu S; Lin C; Li B; Wang X; Long M; Guo F
    New Microbiol; 2011 Oct; 34(4):371-8. PubMed ID: 22143810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams.
    Gunkel AG; Hechler U; Martin HH
    J Gen Microbiol; 1991 Feb; 137(2):243-52. PubMed ID: 2016583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia.
    Weinstein RJ; Young LS; Hewitt WL
    J Lab Clin Med; 1975 Nov; 86(5):853-62. PubMed ID: 810533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Carbenicillin resistance of gram-negative bacteria: incidence, biochemical and genetic determinism].
    Shaokat S; Joly B; Philippon A; Sirot D; Cluzel R
    Pathol Biol (Paris); 1985 Oct; 33(8):825-9. PubMed ID: 3903620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. R plasmids coding for gentamicin, tobramycin, and carbenicillin resistance in Serratia, Klebsiella and Escherichia coli strains from a single clinical source.
    Knothe H; Kettner M; Kopsová D; Krcméry V
    Chemotherapy; 1977; 23(1):37-43. PubMed ID: 401718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary report on beta-lactamase isoenzymes of clinical isolates of Pseudomonas aeruginosa and carbenicillin-resistance.
    Saoji AM; Kelkar SS
    Indian J Med Res; 1981 Apr; 73():503-9. PubMed ID: 6790426
    [No Abstract]   [Full Text] [Related]  

  • 38. Frequency of beta-lactamases that are markedly active against carbenicillin in the Pseudomonas aeruginosa strains isolated in a medical school hospital.
    Jouvenot M; Bonin P; Michel-Briand Y
    J Antimicrob Chemother; 1983 Nov; 12(5):451-8. PubMed ID: 6423610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases.
    Queenan AM; Shang W; Schreckenberger P; Lolans K; Bush K; Quinn J
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3485-7. PubMed ID: 17005839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of beta-lactam resistance in British isolates of Pseudomonas aeruginosa.
    Williams RJ; Livermore DM; Lindridge MA; Said AA; Williams JD
    J Med Microbiol; 1984 Jun; 17(3):283-93. PubMed ID: 6327987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.